Hurel Corporation's Series A - II Round

Hurel Corporation raised a round of funding on June 28, 2013. Investors include The Humane Society of the United States.

Hurel Corporation is a world-leading provider of advanced liver tissue constructs and microfluidic cell-based assay platforms that are used in pre-clinical drug development by major pharmaceutical and…

Articles about Hurel Corporation's Series A - II Round: